Notable Labs Past Earnings Performance

Past criteria checks 0/6

Notable Labs has been growing earnings at an average annual rate of 39.8%, while the Biotechs industry saw earnings growing at 19% annually. Revenues have been growing at an average rate of 3812.5% per year.

Key information

39.8%

Earnings growth rate

-24.9%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth rate3,812.5%
Return on equity-146.7%
Net Margin-3,368.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Notable Labs makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:NTBL.Q Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-11106
31 Mar 240-985
31 Dec 230-11105
30 Sep 230-1385
30 Jun 230-1885
31 Mar 230-1877
31 Dec 220-1458
31 Dec 210-16611

Quality Earnings: NTBL.Q is currently unprofitable.

Growing Profit Margin: NTBL.Q is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if NTBL.Q's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare NTBL.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NTBL.Q is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15%).


Return on Equity

High ROE: NTBL.Q has a negative Return on Equity (-146.7%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies